ACTRN12614000455662
Completed
未知
Evaluation of the Outcomes of Renal functions and Urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion in Mild Maternal Hydronephrosis and normal pregnancies
Emre Goksan Pabuccu0 sites86 target enrollmentMay 1, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Mild Maternal Hydronephrosis in Pregnancy
- Sponsor
- Emre Goksan Pabuccu
- Enrollment
- 86
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •singleton pregnancies between 24\-36 weeks of gestation without identifiable maternal and fetal disorders other than maternal hydronephrosis.
Exclusion Criteria
- •\-Active urinary tract infection
- •\-urolithiasis
- •\-known genitourinary anomalies
- •\-gestational or nongestational diabetes mellitus
- •\-preeclampsia
- •\-chronic hypertension
- •\-chronic kidney or liver diseases
- •\-chronic vascular or connective tissue diseases
- •The well\-being of the fetus and the pregnancy was
- •established with a biophysical profile scoring. Pregnancies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-005033-31-FRAddmedica S.A.S
Completed
Not Applicable
Prospective evaluation of renal function and proteinuria in chronic kidney disease patientsProteinuriaJPRN-UMIN000007371Aichi welfare agricultural cooperative association Anjo Kosei Hospital60
Completed
Not Applicable
Influence of renal dysfunction on the outcomes of hepatectomy for hepatocellular carcinomaJPRN-UMIN000041749Hiroshima University238
Active, not recruiting
Phase 1
A study to assess the renal function in young male patients with Fabry disease who have never received any specific treatment for this disease.Fabry diseaseMedDRA version: 15.0Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2012-001966-14-ESGenzyme, a Sanofi Company39
Withdrawn
Phase 4
A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients with Fabry Diseaseinherited enzyme deficiencymetabolic disorder1008362410021605NL-OMON39057Sanofi-aventis3